Literature DB >> 8948366

HIV-1 pol sequences from India fit distinct subtype pattern.

L E Soto-Ramirez1, S Tripathy, B Renjifo, M Essex.   

Abstract

HIV-1 isolates are classified phylogenetically in several subtypes or clades according to env and gag coding sequences. Viral subtypes tend to cluster geographically. DNA sequences encoding the p51 subunit of reverse transcriptase were obtained by nested polymerase chain reaction from peripheral blood mononuclear cells of two HIV-1-seropositive individuals from New Delhi and three from Pune, in northern and western India, respectively. These isolates were previously characterized as subtype C according to their env sequences. Based on phylogenetic analysis, the reverse transcriptase coding region of these isolates is distinct from those of subtype A, subtype B, subtype D, and group O of HIV-1 viruses. The nucleotide divergence of these Indian pol sequences (3.3%) is similar to that of existing sequences for subtype B and subtype D viruses. This result supports the epidemiologic data of a more recently introduced HIV-1 epidemic in India. Based on the corresponding env sequences, the pol sequences described in this report are subtype C.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8948366     DOI: 10.1097/00042560-199612010-00001

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  13 in total

1.  Viral evolution and epidemiology.

Authors:  Katrin Leitmeyer; Rebeca Rico-Hesse
Journal:  Curr Opin Infect Dis       Date:  1997-10       Impact factor: 4.915

2.  Frequency of drug-resistant variants of HIV-1 coexistent with wild-type in treatment-naive patients of India.

Authors:  Naresh Sachdeva; Shobha Sehgal; Sunil K Arora
Journal:  MedGenMed       Date:  2005-07-27

3.  Sequence analysis of the polymerase domain of HIV-1 reverse transcriptase in naive and zidovudine-treated individuals reveals a higher polymorphism in alpha-helices as compared with beta-strands.

Authors:  L Medrano; L Menéndez-Arias; R De Jorge; M L Villahermosa; G Contreras; L Pérez-Alvarez; A Moya; R Nájera
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

4.  Human immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility.

Authors:  C Apetrei; D Descamps; G Collin; I Loussert-Ajaka; F Damond; M Duca; F Simon; F Brun-Vézinet
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Sequence and drug susceptibility of subtype C reverse transcriptase from human immunodeficiency virus type 1 seroconverters in Zimbabwe.

Authors:  R W Shafer; J A Eisen; T C Merigan; D A Katzenstein
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

6.  Determination of human immunodeficiency virus type 1 subtypes by a rapid method useful for the routine diagnostic laboratory.

Authors:  H H Kessler; D Deuretzbacher; E Stelzl; E Daghofer; B I Santner; E Marth
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

7.  Dysregulation through the NF-kappaB enhancer and TATA box of the human immunodeficiency virus type 1 subtype E promoter.

Authors:  M A Montano; C P Nixon; M Essex
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

Review 8.  HIV infection in India: epidemiology, molecular epidemiology and pathogenesis.

Authors:  Samir Lakhashe; Madhuri Thakar; Sheela Godbole; Srikanth Tripathy; Ramesh Paranjape
Journal:  J Biosci       Date:  2008-11       Impact factor: 1.826

9.  Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination.

Authors:  K S Lole; R C Bollinger; R S Paranjape; D Gadkari; S S Kulkarni; N G Novak; R Ingersoll; H W Sheppard; S C Ray
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

10.  Frequency of Drug-Resistant Variants of HIV-1 Coexistent With Wild-Type in Treatment-Naive Patients of India.

Authors:  Naresh Sachdeva; Shobha Sehgal; Sunil K Arora
Journal:  J Int AIDS Soc       Date:  2005-07-27       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.